TFF Pharmaceuticals Announces Inhaled Niclosamide Significantly Inhibits Viral Replication of the Omicron Variant of SARS-CoV-2
Stock Information for TFF Pharmaceuticals Inc - Ordinary Shares
Loading
Please wait while we load your information from QuoteMedia.